Abstract
Here we show a novel mechanism by which FLICE-like inhibitory protein (c-FLIP) regulates apoptosis induced by tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and one of its receptors, DR5. c-FLIP is a critical regulator of the TNF family of cytokine receptor signaling. c-FLIP has been postulated to prevent formation of the competent death-inducing signaling complex (DISC) in a ligand-dependent manner, through its interaction with FADD and/or caspase-8. In order to identify regulators of TRAIL function, we used the intracellular death domain (DD) of DR5 as a target to screen a phage-displayed combinatorial peptide library. The DD of DR5 selected from the library a peptide that showed sequence similarity to a stretch of amino acids in the C terminus of c-FLIP(L). The phage-displayed peptide selectively interacted with the DD of DR5 in in vitro binding assays. Similarly, full-length c-FLIP (c-FLIP(L)) and the C-terminal p12 domain of c-FLIP interacted with DR5 both in in vitro pull-down assays and in mammalian cells. This interaction was independent of TRAIL. To the contrary, TRAIL treatment released c-FLIP(L) from DR5, permitting the recruitment of FADD to the active DR5 signaling complex. By employing FADD-deficient Jurkat cells, we demonstrate that DR5 and c-FLIP(L) interact in a FADD-independent manner. Moreover, we show that a cellular membrane permeable version of the peptide corresponding to the DR5 binding domain of c-FLIP induces apoptosis in mammalian cells. Taken together, these findings indicate that c-FLIP interacts with the DD of DR5, thus preventing death (L)signaling by DR5 prior to the formation of an active DISC. Because TRAIL and DR5 are ubiquitously expressed, the interaction of c-FLIP(L) and DR5 indicates a mechanism by which tumor selective apoptosis can be achieved through protecting normal cells from undergoing death receptor-induced apoptosis.
Highlights
Tumor necrosis factor (TNF)1-related apoptosis-inducing ligand (TRAIL), known as Apo-2 ligand, is a type II mem
One such mechanism involves the cellular inhibitor of apoptosis, cellular FLICE inhibitory protein (c-FLIP), which is known as I-FLICE, FLAME, CASPER, or CASH [31,32,33,34,35,36,37,38]. cFLIP exists as a long (c-FLIPL) or as a short (c-FLIPS) splice variant (1, 8, 39 – 42). c-FLIPL contains two death effector domains (DED) and an inactive caspase domain composed of p17 and p12 subunits [39, 40]
Cellular mechanisms must exist to keep signaling from TRAIL receptors in check. c-FLIP has been generally regarded as a critical regulator of death-receptor mediated apoptosis through its association with and inhibition of caspase-8/10 at the death-inducing signaling complex (DISC)
Summary
Tumor necrosis factor (TNF)1-related apoptosis-inducing ligand (TRAIL), known as Apo-2 ligand, is a type II mem-. Because of the tumor selectivity of TRAIL-induced apoptosis and its ubiquitous expression, it has been postulated that the apoptosis pathway induced by TRAIL is tightly regulated by several mechanisms to prevent spontaneous cell death One such mechanism involves the cellular inhibitor of apoptosis, cellular FLICE inhibitory protein (c-FLIP), which is known as I-FLICE, FLAME, CASPER, or CASH [31,32,33,34,35,36,37,38]. TNF-related apoptosis-inducing ligand; FADD, Fas-associated protein with death domain; DED, death effector domain; HEK, human embryonic kidney cell; GST, glutathione S-transferase; DISC, death-inducing signaling complex; SODD, silencer of death domains; ELISA, enzymelinked immunosorbent assay; DD, death domain; c-FLIP, cellular FLICE-like inhibitory protein; c-FLIPL, long form of c-FLIP; c-FLIPS, short variant of c-FLIP; DR, death receptor. Another c-FLIP variant, c-FLIPp43 is the product of caspase cleavage of full-length c-FLIPL [39, 40]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.